Louisiana State University, School of Veterinary Medicine, Department of Veterinary Clinical Sciences, 1909 Skip Bertman Dr., Baton Rouge, LA 70803, USA.
Louisiana State University, Department of Pathobiological Sciences, 1909 Skip Bertman Dr., Baton Rouge, LA 70803, USA; Louisiana State University, Louisiana Animal Disease Diagnostic Laboratory (LADDL), River Rd, #1043, Baton Rouge, LA 70803, USA.
Res Vet Sci. 2022 Oct;147:83-91. doi: 10.1016/j.rvsc.2022.04.005. Epub 2022 Apr 22.
Cutaneous canine mast cell tumors (ccMCTs) vary in their biological behavior, treatment, and prognosis, based on their grade. Immune cell infiltration has been associated with prognosis and response to treatments in some human cancers, and immune-targeting therapeutics are increasingly being explored in veterinary oncology. However, currently little is known about the tumor microenvironment (TME) in ccMCTs. Therefore, the objective of this study was to determine the prevalence of T lymphocytes, T regulatory lymphocytes, PD-1+ cells and macrophages in low- and high-grade ccMCTs. Thirty low-grade and 20 high-grade formalin-fixed paraffin-embedded ccMCT samples were included. Immunohistochemistry (IHC) was performed to detect CD3, FOXP3, Iba1, and PD-1 on sequential sections. Three 400x fields with the highest numbers of CD3+ cells were identified for each tumor. The percentage of CD3+, FOXP3+, and Iba1+ cells, and the number of PD-1+ cells, was quantified in each of these three "hot-spot" fields using ImageJ software. Iba1 expression was significantly greater in high-grade compared to low-grade ccMCTs (mean = 12.5% vs. 9.6%, p = 0.043). PD-1 expression was low overall, but a significantly higher number of PD-1-expressing cells was observed in high-grade ccMCTs (median 1 vs. 0, p = 0.001). No significant difference was noted in CD3 and FOXP3 expression between ccMCT grades. Macrophages and PD-1+ cells were more frequent in high-grade, compared to low-grade ccMCTs. Further studies are needed to define the role of macrophages and rare PD-1+ cells in high-grade ccMCTs.
皮肤犬肥大细胞瘤(ccMCT)根据其分级在生物学行为、治疗和预后方面存在差异。免疫细胞浸润与某些人类癌症的预后和对治疗的反应有关,免疫靶向治疗在兽医肿瘤学中越来越受到关注。然而,目前对于 ccMCT 的肿瘤微环境(TME)知之甚少。因此,本研究的目的是确定低级别和高级别 ccMCT 中 T 淋巴细胞、T 调节性淋巴细胞、PD-1+细胞和巨噬细胞的患病率。纳入了 30 例低级别和 20 例高级别福尔马林固定石蜡包埋的 ccMCT 样本。采用免疫组织化学(IHC)检测连续切片上的 CD3、FOXP3、Iba1 和 PD-1。为每个肿瘤鉴定了具有最高数量 CD3+细胞的三个 400x 视野。使用 ImageJ 软件对这三个“热点”视野中的每个视野中的 CD3+、FOXP3+和 Iba1+细胞的百分比以及 PD-1+细胞的数量进行量化。与低级别 ccMCT 相比,高级别 ccMCT 中 Iba1 的表达明显更高(平均值=12.5%对 9.6%,p=0.043)。PD-1 的表达总体较低,但在高级别 ccMCT 中观察到的 PD-1 表达细胞数量明显更高(中位数 1 对 0,p=0.001)。ccMCT 分级之间 CD3 和 FOXP3 的表达无显著差异。与低级别 ccMCT 相比,高级别 ccMCT 中巨噬细胞和 PD-1+细胞更为常见。需要进一步的研究来确定巨噬细胞和罕见的 PD-1+细胞在高级别 ccMCT 中的作用。